Q4FY18 result highlights Net revenues were down 15%yoy (flat qoq) to Rs4.5bn, below our estimates of Rs5bn; Both CRAMS and MM segments were lower yoy. FY18 revenue of Rs16.96bn is marginally lower yoy. Adjusted for the change in the accounting treatment for unrealized forex gains, revenues were marginally higher qoq. Other operating income was negative Rs10.6mn vs Rs289mn (realised forex gains of Rs175mn) in Q3FY18 and Rs471mn in Q4FY18. Led by lower revenues, reported EBITDA stood lower at...
Q4FY18 result highlights Net revenues were down 15%yoy (flat qoq) to Rs4.5bn, below our estimates of Rs5bn; Both CRAMS and MM segments were lower yoy. FY18 revenue of Rs16.96bn is marginally lower yoy. Adjusted for the change in the accounting treatment for unrealized forex gains, revenues were marginally higher qoq. Other operating income was negative Rs10.6mn vs Rs289mn (realised forex gains of Rs175mn) in Q3FY18 and Rs471mn in Q4FY18. Led by lower revenues, reported EBITDA stood lower at...
The general evaluation of DISHMAN PHARMS.& CHML. (IN), a company active in the Pharmaceuticals industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as defensive. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Positive. As of the analysis date June 23, 2017, the closing price was INR 301.20...
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.